AFP and gastric carcinoma: Furthermore, addition of rapamycin diminished the residual activity of mTORC1 and significantly intensified the cytotoxicity of cisplatin in the gastric carcinoma cells producing alpha-fetoprotein (AFP) to be resistant to cisplatin [48].